Clinical Trials Browser

Phase 3 × ferumoxtran-10 × 90 days × Clear all

NCT04261777 2026-04-28

Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients

Phase 3 Terminated

Neoplasm Metastasis, Prostatic Neoplasms